Filgrastim Biosimilar (VA-27-00012533)
Open Pre-Solicitation Posted
- Solicitation number
- 36E79727R0001
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is gathering market information on filgrastim biosimilar products ahead of a formal competitive solicitation, with responses due December 15, 2026. No set-aside is used. The notice (VA-27-00012533) is posted as a Pre-Solicitation under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals). Its attached document, 36E79727R0001_1.docx, is described in the derived government-file summary as a request for information seeking product availability, FDA-approved and bioequivalent product specifications, manufacturing capacity, regulatory status, shelf life, storage requirements, quality assurance protocols, supply chain capacity, and proposed pricing structures. The summary emphasizes cGMP standards and compliance with applicable federal regulations. Supply is described as serving VA healthcare facilities nationwide. The response instructions reside in the attached document.
Notice text
Please see attached documents.
Files
| File | Type | Posted |
|---|---|---|
| 36E79727R0001_1.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--FY27 Lenalidomide BPA | Veterans Integrated Service Network 22 | No set-aside | |
| 6505--Latanoprost Ophthalmic Solution (VA-27-00006027) | National Acquisition Center | No set-aside | |
| Flow Cytometry Reagents | Veterans Integrated Service Network 5 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity